-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Psilocybin in Cluster Headache Syndrome (Cluster Headache)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Psilocybin in Cluster Headache Syndrome (Cluster Headache) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Psilocybin in Cluster Headache Syndrome (Cluster Headache) Drug Details:...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Psilocybin in Migraine
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Psilocybin in Migraine report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Psilocybin in Migraine Drug Details: Psilocybin is under investigation for the treatment of...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Psilocybin in Smoking Cessation
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Psilocybin in Smoking Cessation report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Psilocybin in Smoking Cessation Drug Details: Psilocybin is under investigation for the...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – (Cisplatin + Vinblastine Sulphate) in Metastatic Hepatocellular Carcinoma (HCC)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - (Cisplatin + Vinblastine Sulphate) in Metastatic Hepatocellular Carcinoma (HCC) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. (Cisplatin + Vinblastine Sulphate) in Metastatic Hepatocellular...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – Brexanolone in Anxiety Disorders
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Brexanolone in Anxiety Disorders report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Brexanolone in Anxiety Disorders Drug Details: Brexanolone is under development for the...
-
Product Insights
Obsessive-Compulsive Disorder – Drugs In Development, 2023
Global Markets Direct’s, ‘Obsessive-Compulsive Disorder - Drugs In Development, 2023’, provides an overview of the Obsessive-Compulsive Disorder pipeline landscape. The report provides comprehensive information on the therapeutics under development for Obsessive-Compulsive Disorder, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an...
-
Product Insights
Cluster Headache Syndrome (Cluster Headache) – Drugs In Development, 2023
Global Markets Direct’s, ‘Cluster Headache Syndrome (Cluster Headache) - Drugs In Development, 2023’, provides an overview of the Cluster Headache Syndrome (Cluster Headache) pipeline landscape. The report provides comprehensive information on the therapeutics under development for Cluster Headache Syndrome (Cluster Headache), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest...
-
Product Insights
Lyme Disease – Drugs In Development, 2023
Global Markets Direct’s, ‘Lyme Disease - Drugs In Development, 2023’, provides an overview of the Lyme Disease pipeline landscape. The report provides comprehensive information on the therapeutics under development for Lyme Disease, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an...
-
Product Insights
Smoking Cessation – Drugs In Development, 2023
Global Markets Direct’s, ‘Smoking Cessation - Drugs In Development, 2023’, provides an overview of the Smoking Cessation pipeline landscape. The report provides comprehensive information on the therapeutics under development for Smoking Cessation, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an...